() Cloxamp DC 600 Intramammary | Norbrook Laboratories

Cloxamp DC 600

Cloxamp DC 600 is an off-white stable, sterile intramammary suspension. Each syringe contains 4.5g of suspensions containing Cloxacillin (as benzathine salt) 600mg and ampicillin (as trihydrate) 300mg in a long acting base. For the treatment of dairy cows at drying off only, that is immediately after the last milking of the lactation. To treat existing mastitis caused by, or associated with, organisms sensitive to cloxacillin and ampicillin. To provide prolonged protection against further infections during the dry period.

Target Species: Dairy Cattle

  • Active Ingredient

    Cloxacillin (as benzathine salt) 600mg and ampicillin (as trihydrate) 300mg in a 5.4g syringe

  • Pharmaceutical Form

    Intramammary preparation

  • Indications

    This product is indicated for the treatment of dairy cows at drying off only, that is immediately after the last milking of the lactation. To treat existing mastitis caused by, or associated with, organisms sensitive to cloxacillin and ampicillin. To provide prolonged protection against further infections during the dry period.

  • Dosage

    Read the entire label prior to use. Taking antiseptic precautions, introduce contents of one injector into each quarter via the teat canal. Treat after the final milking of the lactation, and at least 49 days before calving. The variable tip allows for either full or partial insertion into the teat orifice. Partial insertion only is preferable, as it may prevent unnecessary damage to the teat orifice and reduce the risk of infection. Full insertion will be needed for large teat orifices

  • Prudent Use Statement

    Ampicillin and cloxacillin are antibiotics in the penicillin family and are considered Highly Important to human and animal health. The use of these antibiotics should only be for the minimum period needed to meet the clinical objective. Clinical response to these antibiotics should be monitored during treatment, and choice of therapy reviewed if clinical signs of disease persist, increase, or relapse. In the event of treatment failure, culture and sensitivity should be considered to determine an appropriate alternative therapy. Indiscriminate use of these antibiotics can contribute to the development of antibiotic resistance.

Prefer to speak directly to a member of our team?

Norbrook® Laboratories New Zealand Ltd

We are open Mon - Fri 9:00am - 5:00pm

Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.